177 related articles for article (PubMed ID: 33218896)
41. Coumarin derivatives with anticancer activities: An update.
Song XF; Fan J; Liu L; Liu XF; Gao F
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000025. PubMed ID: 32383190
[TBL] [Abstract][Full Text] [Related]
42. Development of Mcl-1 inhibitors for cancer therapy.
Negi A; Murphy PV
Eur J Med Chem; 2021 Jan; 210():113038. PubMed ID: 33333396
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and Biological Evaluation of Novel Thiazolyl-Coumarin Derivatives as Potent Histone Deacetylase Inhibitors with Antifibrotic Activity.
Pardo-Jiménez V; Navarrete-Encina P; Díaz-Araya G
Molecules; 2019 Feb; 24(4):. PubMed ID: 30791388
[TBL] [Abstract][Full Text] [Related]
44. Design, Synthesis and Biological Evaluation of 4, 6-Coumarin Derivatives as Anti- Cancer and Apoptosis-Inducing Agents.
Yan G; Luo J; Han X; Zhang W; Pu C; Zhou M; Zhong X; Hou X; Hou MZ; Li R
Anticancer Agents Med Chem; 2021; 21(17):2351-2367. PubMed ID: 33511941
[TBL] [Abstract][Full Text] [Related]
45. Structure-activity relationship studies of 4-methylcoumarin derivatives as anticancer agents.
Miri R; Nejati M; Saso L; Khakdan F; Parshad B; Mathur D; Parmar VS; Bracke ME; Prasad AK; Sharma SK; Firuzi O
Pharm Biol; 2016; 54(1):105-10. PubMed ID: 26017566
[TBL] [Abstract][Full Text] [Related]
46. Synthesis, in vitro antiproliferative activity, and in silico studies of fused tricyclic coumarin sulfonate derivatives.
El-Gamal MI; Oh CH
Eur J Med Chem; 2014 Sep; 84():68-76. PubMed ID: 25016229
[TBL] [Abstract][Full Text] [Related]
47. Discovery of novel HSP90 inhibitors that induced apoptosis and impaired autophagic flux in A549 lung cancer cells.
Wei Q; Ning JY; Dai X; Gao YD; Su L; Zhao BX; Miao JY
Eur J Med Chem; 2018 Feb; 145():551-558. PubMed ID: 29339250
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and anticancer activity of 6-heteroarylcoumarins.
Galayev O; Garazd Y; Garazd M; Lesyk R
Eur J Med Chem; 2015 Nov; 105():171-81. PubMed ID: 26491980
[TBL] [Abstract][Full Text] [Related]
49. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies.
Singh H; Singh JV; Gupta MK; Saxena AK; Sharma S; Nepali K; Bedi PMS
Bioorg Med Chem Lett; 2017 Sep; 27(17):3974-3979. PubMed ID: 28797799
[TBL] [Abstract][Full Text] [Related]
50. Indole-coumarin-thiadiazole hybrids: An appraisal of their MCF-7 cell growth inhibition, apoptotic, antimetastatic and computational Bcl-2 binding potential.
Kamath PR; Sunil D; Joseph MM; Abdul Salam AA; T T S
Eur J Med Chem; 2017 Aug; 136():442-451. PubMed ID: 28525842
[TBL] [Abstract][Full Text] [Related]
51. Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis.
Mohamed TK; Batran RZ; Elseginy SA; Ali MM; Mahmoud AE
Bioorg Chem; 2019 Apr; 85():253-273. PubMed ID: 30641320
[TBL] [Abstract][Full Text] [Related]
52. An efficient one-pot approach for the regio- and diastereoselective synthesis of trans-dihydrofuran derivatives: cytotoxicity and DNA-binding studies.
Tangella Y; Manasa KL; Laxma Nayak V; Sathish M; Sridhar B; Alarifi A; Nagesh N; Kamal A
Org Biomol Chem; 2017 Aug; 15(32):6837-6853. PubMed ID: 28782777
[TBL] [Abstract][Full Text] [Related]
53. Click chemistry inspired synthesis and bioevaluation of novel triazolyl derivatives of osthol as potent cytotoxic agents.
Farooq S; Shakeel-u-Rehman ; Hussain A; Hamid A; Qurishi MA; Koul S
Eur J Med Chem; 2014 Sep; 84():545-54. PubMed ID: 25062005
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and biological evaluation of 4-(1,2,3-triazol-1-yl)coumarin derivatives as potential antitumor agents.
Zhang W; Li Z; Zhou M; Wu F; Hou X; Luo H; Liu H; Han X; Yan G; Ding Z; Li R
Bioorg Med Chem Lett; 2014 Feb; 24(3):799-807. PubMed ID: 24418772
[TBL] [Abstract][Full Text] [Related]
55. Design, synthesis, and evaluation of novel coumarin-dithiocarbamate derivatives (IDs) as anti-colorectal cancer agents.
Zhu H; Ying S; Zhou B; Hu X; Liang X; Li W; Wang D; Jin H; Pan Y
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):593-604. PubMed ID: 33557648
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and antiproliferative activity of new coumarin-based benzopyranone derivatives against human tumor cell lines.
Musa MA; Zhou A; Sadik OA
Med Chem; 2011 Mar; 7(2):112-20. PubMed ID: 21222615
[TBL] [Abstract][Full Text] [Related]
57. Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide - A new caspase-activating proapoptotic agent.
Dar'in D; Kantin G; Kalinin S; Sharonova T; Bunev A; Ostapenko GI; Nocentini A; Sharoyko V; Supuran CT; Krasavin M
Eur J Med Chem; 2021 Oct; 222():113589. PubMed ID: 34147910
[TBL] [Abstract][Full Text] [Related]
58. Novel 3-aryl-5-substituted-coumarin analogues: Synthesis and bioactivity profile.
Kavetsou E; Katopodi A; Argyri L; Chainoglou E; Pontiki E; Hadjipavlou-Litina D; Chroni A; Detsi A
Drug Dev Res; 2020 Jun; 81(4):456-469. PubMed ID: 31943295
[TBL] [Abstract][Full Text] [Related]
59. Coumarins as anticancer agents: a review on synthetic strategies, mechanism of action and SAR studies.
Thakur A; Singla R; Jaitak V
Eur J Med Chem; 2015 Aug; 101():476-95. PubMed ID: 26188907
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and anticancer activity of new coumarin-3-carboxylic acid derivatives as potential lactatetransportinhibitors.
Ji H; Tan Y; Gan N; Zhang J; Li S; Zheng X; Wang Z; Yi W
Bioorg Med Chem; 2021 Jan; 29():115870. PubMed ID: 33221062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
